Reliability of Ultrasound Metrics Used in Hip Dysplasia Diagnostics - a Prospective Study
NCT ID: NCT06233487
Last Updated: 2024-08-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
110 participants
INTERVENTIONAL
2024-02-27
2024-11-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This study will evaluate three ultrasound measurement methodologies in a high quality controlled setting, to investigate the best achieveable reliability and agreement of the investigated measurements used in hip dysplasia diagnostics.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Diagnostic Efficacy Study of AI System in Screening Infants With Developmental Dysplasia of the Hip
NCT06803004
Evaluation of the Effectiveness of Developmental Hip Dysplasia Screening in Risk Groups
NCT07066852
Normative Radiographic Parameters and Growth Curve of Hips Less Than Six Weeks of Gestational Age Using Ultrasound
NCT03109444
Mid-term Functional Comparisons of Unilateral and Bilateral Developmental Dysplasia of the Hip
NCT05853510
Ultrasound Predictors of Early Pregnancy Failure in Patients With Recurrent Pregnancy Loss
NCT03178682
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The pubo-femoral distance (PFD) was proposed in 2013 as a new measurement for assessing DDH, while the reliability is reportedly higher than the gold standard US methods, it has never been directly compared to these.
This study aims to evaluate the inter- and intrarater reliability of Graf's alpha and beta angles, the FHC and PFD in children referred for hip US in a selective ultrasound screening program for DDH.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Double measurements
All included children will have double measurements of the investigated ultrasound methodologies performed by two separate musculoskeletal radiologists.
Repeat hip ultrasound measurements
See earlier
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Repeat hip ultrasound measurements
See earlier
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Children receiving follow-up ultrasound for previously diagnosed DDH
Exclusion Criteria
0 Months
6 Months
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Aalborg University Hospital
OTHER
Aarhus University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hans-Christen Husum
Postdoctoral Research Fellow, Department of Radiology, Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Aarhus University Hospital
Aarhus, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Hans-Christen Husum, MD, PhD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1-49-72-4-18
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.